Study expands access to whole genome sequencing in people with Parkinson’s disease, suggesting enhanced healthcare opportunities.
Expanding access to clinical whole genome sequencing (WGS) and genetic counseling on a global scale to people living with Parkinson’s disease (PD).
No takes yet. Share an insight, caveat, or question.
Beck et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: